Sadé. Innovative Cannabis Science.

     We combine the best of what Israel can offer to the world: people, biotech, agritech, and science - to make natural remedies and wellness products available while providing employment for local communities and effective returns to our investors

Amit SadeFounder, CEO

About Sadé

Sadé Group is geared to be a global leader in bringing innovative pharma-grade cannabis products to market . The company was founded as a leading scientific research company with its initial projects focusing on cannabis cultivation, as well as genetic and applied research, by scientists at the ARO, Israel’s government Agricultural Research Organization

Pharma-grade Cannabis Products

Genetic Research & Big Data Mapping

Advanced Agriculture & Breeding Technologies

The company expanded on its knowledge of growing for research purposes – and upscaled it to include clinical research and GMP manufacturing for multiple industries

 Sadé Global Reach       

FROM PLANT GENETICS TO CLINICAL STUDIES

CANNABIS IN NUMBERS

AN INDUSTRY READY TO BLOOM

$67
Bn

Medical cannabis global market 2020

40+
Patents

Sade 2019: number of registered patents on genes, strains, varieties and medical products

$146
Bn

Legal marijuana market in 2025

7.8
Tonnes

Sadé GAP/GMP certified medical cannabis yield in 2020

Sapir 8. St.
Nes Ziona

Israel

contact@sade.group

© 2018 by Sade Group